2-222201414-G-A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 1P and 14B. PP2BP4_StrongBP6_ModerateBS1BS2

The ENST00000344493.9(PAX3):​c.1202C>T​(p.Ser401Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000172 in 1,613,744 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00018 ( 2 hom. )

Consequence

PAX3
ENST00000344493.9 missense

Scores

1
3
11

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.951

Publications

0 publications found
Variant links:
Genes affected
PAX3 (HGNC:8617): (paired box 3) This gene is a member of the paired box (PAX) family of transcription factors. Members of the PAX family typically contain a paired box domain and a paired-type homeodomain. These genes play critical roles during fetal development. Mutations in paired box gene 3 are associated with Waardenburg syndrome, craniofacial-deafness-hand syndrome, and alveolar rhabdomyosarcoma. The translocation t(2;13)(q35;q14), which represents a fusion between PAX3 and the forkhead gene, is a frequent finding in alveolar rhabdomyosarcoma. Alternative splicing results in transcripts encoding isoforms with different C-termini. [provided by RefSeq, Jul 2008]
PAX3 Gene-Disease associations (from GenCC):
  • craniofacial-deafness-hand syndrome
    Inheritance: AD, Unknown Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • Waardenburg syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Waardenburg syndrome type 1
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • Waardenburg syndrome type 3
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 47 curated pathogenic missense variants (we use a threshold of 10). The gene has 9 curated benign missense variants. Gene score misZ: 1.618 (below the threshold of 3.09). Trascript score misZ: 1.7366 (below the threshold of 3.09). GenCC associations: The gene is linked to Waardenburg syndrome type 3, Waardenburg syndrome type 1, Waardenburg syndrome, craniofacial-deafness-hand syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.017596334).
BP6
Variant 2-222201414-G-A is Benign according to our data. Variant chr2-222201414-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 227834.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000132 (20/151944) while in subpopulation EAS AF = 0.00155 (8/5162). AF 95% confidence interval is 0.000771. There are 0 homozygotes in GnomAd4. There are 7 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR,AD,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PAX3NM_181458.4 linkc.1449C>T p.Ile483Ile synonymous_variant Exon 9 of 9 ENST00000392070.7 NP_852123.1 P23760-7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PAX3ENST00000392070.7 linkc.1449C>T p.Ile483Ile synonymous_variant Exon 9 of 9 1 NM_181458.4 ENSP00000375922.3 P23760-7

Frequencies

GnomAD3 genomes
AF:
0.000132
AC:
20
AN:
151944
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000726
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000656
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00155
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.000958
GnomAD2 exomes
AF:
0.000140
AC:
35
AN:
250390
AF XY:
0.0000812
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.0000868
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000708
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000142
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000176
AC:
257
AN:
1461800
Hom.:
2
Cov.:
34
AF XY:
0.000164
AC XY:
119
AN XY:
727200
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33480
American (AMR)
AF:
0.0000894
AC:
4
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.000227
AC:
9
AN:
39692
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53388
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
0.000142
AC:
158
AN:
1111972
Other (OTH)
AF:
0.00139
AC:
84
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
15
29
44
58
73
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000132
AC:
20
AN:
151944
Hom.:
0
Cov.:
31
AF XY:
0.0000943
AC XY:
7
AN XY:
74206
show subpopulations
African (AFR)
AF:
0.0000726
AC:
3
AN:
41346
American (AMR)
AF:
0.0000656
AC:
1
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00155
AC:
8
AN:
5162
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10566
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68018
Other (OTH)
AF:
0.000958
AC:
2
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000355
Hom.:
1
Bravo
AF:
0.000200
ExAC
AF:
0.000157
AC:
19
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000593

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Jan 21, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

c.1202C>T (p.Ser401Leu) in exon 8E of PAX3: This variant is not expected to hav e clinical significance. It is located in an alternate transcript (NM_181461.3) in which the variant nucleotide (T) is present in over 10 mammals, despite high conservation at the adjacent nucleotides. This variant is also translated to a silent variant in the major transcript (NM_001127366.2, c.1446C>T, p.Ile482Ile) , and it is in noncoding regions of other alternate transcripts (NM_000438.5, NM _013942.4, NM_181457.3). This variant has been identified in 0.1% (9/8612) of E ast Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.bro adinstitute.org). In summary, this variant is likely benign due to the lack of nucleotide conservation and predicted impact on the gene function. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
0.048
T
BayesDel_noAF
Pathogenic
0.19
CADD
Benign
9.0
DANN
Benign
0.90
Eigen
Benign
0.12
Eigen_PC
Benign
0.087
FATHMM_MKL
Benign
0.56
D
LIST_S2
Benign
0.33
T;T
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.018
T;T
MetaSVM
Uncertain
0.070
D
PhyloP100
0.95
PROVEAN
Benign
-2.0
N;N
REVEL
Uncertain
0.49
Sift
Benign
0.12
T;D
Sift4G
Benign
0.092
T;D
Polyphen
0.0
B;B
Vest4
0.29
MutPred
0.37
Gain of catalytic residue at S401 (P = 0.011);Gain of catalytic residue at S401 (P = 0.011);
MVP
0.55
ClinPred
0.045
T
GERP RS
0.85
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs757964568; hg19: chr2-223066133; API